Carcinogenesis · 2013 · 61 citations · 29 references
MedicineOncologyPharmacologyCancer PharmacologyChemotherapyMolecular OncologyCancer EpigeneticsCombination Cancer TherapyMalignant NeoplasmsMyelodysplastic SyndromesTargeted Cancer TherapyCancer Combination TherapyDna Methylation ModulationEpigenetic Silencing Of Tumor Suppressor GenesEpigenetic TherapiesGlobal Dna MethylationMethylating AgentsTherapeutic EpigeneticsTumor Cell Invasiveness
DNA-demethylating agents activate tumor suppressor genes that are silenced by DNA methylation in cancer and are therefore emerging as a novel approach to cancer therapy. 5-azacytidine (VIDAZA), the first representative of this class of drugs was approved for treatment of myelodysplastic syndromes and is currently being tested on other cancers including solid tumors. However, 5-azacytidine or its deoxy-analog, 5-aza-2'-deoxycytidine (5-azaCdR) could also induce methylated prometastatic genes by DNA demethylation and induce cancer cell invasiveness. Since 5-azacytidine is a potent cancer growth inhibitor, we tested whether combining it with a DNA-methylating agent, the methyl donor S-adenosyl methionine (SAM), would block the adverse demethylating activity of 5-azaCdR while maintaining its growth suppression effects. We show here using several invasive and non-invasive breast cancer cell lines that SAM inhibits global- and gene-specific demethylation induced by 5-azaCdR, prevents 5-azaCdR activation of prometastatic genes uPA and MMP2, resulting in inhibition of cell invasiveness while augmenting the growth inhibitory effects of 5-azaCdR and its effects on tumor suppressor genes. Combination of drugs acting on the DNA methylation machinery at different levels is proposed as a new strategy for epigenetic therapy of cancer.
29
High sensitivity mapping of methylated cytosines
J.CIark Susan, Cheryl Paul, Marianne Frommer · Nucleic Acids Research · 1994 · 1.9K citations · Full text
Purification of RNA Using TRIzol (TRI Reagent)
Donald C. Rio, Manuel Ares, Gregory J. Hannon et al. · Cold Spring Harbor Protocols · 2010 · 1.8K citations
DNA hypomethylation leads to elevated mutation rates
Richard Z. Chen, Ulf Pettersson, Caroline Beard et al. · Nature · 1998 · 954 citations
Reduced genomic 5-methylcytosine content in human colonic neoplasia.
Andrew P. Feinberg, Charles W. Gehrke, Kenneth C. Kuo et al. · PubMed · 1988 · 490 citations